Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
Real-world Effectiveness of PD-(L)1 Inhibitors Alone or in Combination with Chemotherapy in First-line PDL1-high Non-squamous Lung Cancer
- Start date
- 08 Apr 2021
- End date
- 09 Apr 2021
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.
Programme
Thursday 8 April
Welcome and introduction, Scientific background and context
Natasha Leighl, Princess Margaret Cancer Centre, Toronto, ON, Canada
Real world effectiveness of PD-(L)1 inhibitors alone or in combination with chemotherapy in first-line PDL1-high non-squamous lung cancer
Solange Peters, Centre Hospitalier Universitaire Vaudois – CHUV, Lausanne, Switzerland
Critical analysis and perspectives
Federico Cappuzzo, Istituto Nazionale Tumori Regina Elena, Rome, Italy
Live discussion and Q&A
Faculty and online audience (via chat feature)
Friday 9 April
Webcast of the ESMO Virtual Plenary plus additional live Discussion and Q&A with Faculty and online audience (via chat feature)
Solange Peters, Centre Hospitalier Universitaire Vaudois – CHUV, Lausanne, Switzerland
Federico Cappuzzo, Istituto Nazionale Tumori Regina Elena, Rome, Italy
Tony SK Mok, Prince of Wales Hospital, Hong Kong, China
Dong-Wan Kim, Seoul National University Hospital, Seoul, Republic of Korea
Daniel Tan, National Cancer Centre Singapore, Singapore
